Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
Thrombectomy Linked to Improved Outcomes in Pediatric Large Vessel Occlusion
February 11th 2022A retrospective analysis of 10 years of stroke admissions suggests pediatric stroke patients with LVO who did not undergo thrombectomy were at 6 times greater risk of moderate to severe disability or death than those who underwent thrombectomy.
Read More
US FDA Approves Eversense E3 CGM System, Allows Use for Up to 6 Months
February 11th 2022Announced on February 11, the approval for Eversense E3 continuous glucose monitoring system allows access to a CGM system with 6 months of longevity and is expected to be available beginning in the second quarter of 2022.
Read More
DOACs Could Lower Bleeding, Hemorrhage Risk vs. Warfarin in Patients with CVT
February 10th 2022An international, retrospective analysis presented at ISC 2022 provides evidence suggesting use of DOACs as a treatment for cerebral venous thrombosis was associated with similar risk of recurrent clots and death as warfarin, but a 65% lower risk of major bleeding.
Read More
Study Suggests Risk of In-Hospital Mortality from Stroke 42% Greater During Pandemic
February 10th 2022A meta-analysis presented at ISC 2022 suggests the risk of in-hospital mortality for stroke-related admissions was 42% greater among patients hospitalized during the pandemic compared to prepandemic.
Read More
Poor Sleep Health Linked to Significant Increase in Risk of Cardiovascular Disease
February 9th 2022Using a pair of composite scores for measuring sleep health, new research from USF demonstrates the impact poor sleep health can have on risk of cardiovascular disease among adults in midlife.
Read More
Tirzepatide Shows Utility as Add-On Therapy to Titrated Insulin in Type 2 Diabetes
February 8th 2022Data from the SURPASS-5 trial demonstrate the safety and efficacy of multiple tirzepatide doses as an add-on therapy to titrated insulin glargine for glycemic control and weight loss in patients with type 2 diabetes.
Read More
Gestational Diabetes Increases Long-Term Risk for Wide Array of Cardiovascular Conditions
February 7th 2022Analysis of the UK Biobank cohort suggests presence of gestational diabetes was associated with a 33% increase in risk of CAD, 67% increase in risk of myocardial infarction, 69% increase in risk of stroke, and 42% increase in risk heart failure.
Read More
SCAI Releases New Statement on Sex-Based Considerations in Myocardial Revascularization
February 4th 2022Released on February 4, the latest expert consensus statement from the Society for Cardiovascular Angiography and Interventions provides clinicians with an overview of available knowledge related to myocardial revascularization in women and calls attention to existing gaps in knowledge.
Read More
Increased Oxytocin Levels Could Be Driving Hypersexual Disorder in Men
February 3rd 2022New research suggests men with hypersexual disorder had increased plasma oxytocin levels and indicate cognitive-behavioral therapy was associated with a decrease in these levels as well as symptoms of hypersexual disorder.
Read More
REDUCE LAP-HF II: Atrial Shunt Trial in HFpEF Returns Mixed Results
February 2nd 2022Atrial shunt placement failed to reduce heart failure events or improve health status in the overall trial, but results suggest a subgroup of patients with a normal response on an exercise test could stand to benefit from the therapy.
Read More
SCAI Releases Updated Shock Classification Statement
February 1st 2022Released on Jan. 31, the updated consensus statement from the Society for Cardiovascular Angiography and Interventions provides a 3-axis model for shock classification and represents the first update since the original statement was released in 2019.
Read More
FDA Approves Omnipod 5 Automated Insulin Delivery System for Type 1 Diabetes in Ages 6 and Older
January 28th 2022Announced on Jan. 28, the Omnipod 5 AID becomes the first tubeless automated insulin delivery system with the ability to integrate with the Dexcom G6 continuous glucose Monitoring System and a compatible smartphone to automatically adjust insulin and protect against glycemic events
Read More
Hospitalizations for Hypertension Increasing in the US
January 27th 2022An analysis of the National Inpatient Sample suggests the rates of hospitalization for hypertension crises increased from 2002 to 2015, but the rate of in-hospital death during these crises decreased during the same period.
Read More
Study Raises Alarm Over Risk of Chronic Kidney Disease, Rising Obesity Rates in Type 1 Diabetes
January 26th 2022An analysis of data from more than 135k patients with type 1 and type 2 diabetes indicates the age-adjusted rate of chronic kidney disease was greater in type 1 diabetes and also sheds light on the rising rate of obesity in type 1 diabetes.
Read More
Gastric Bypass Associated with Greater Medication Discontinuation than Sleeve Gastrectomy
January 21st 2022A comparative effectiveness study of Medicare claims data suggests gastric bypass surgery was associated with a greater rate of discontinuation of medications for obesity-related comorbidities than sleeve gastrectomy.
Read More
American Heart Association Issues Advisory on Penicillin Injections in Rheumatic Heart Disease
January 20th 2022On January 20, the AHA released a presidential advisory to raise awareness and provide risk mitigation strategies to prevent death from vasovagal compromise following BPG use in patients with rheumatic heart disease.
Read More
NT-proBNP in Early Pregnancy Can Predict HDP, Future Hypertension Risk
January 20th 2022A recent analysis of data from more than 4000 women suggests higher NT-proBNP concentrations during early pregnancy were associated with a 19% reduction in risk of HDP and a 16% reduction in risk of hypertension 2-7 years after delivery.
Read More
Heart Function Recovers Quickly in Adolescents with COVID-19-Related MIS-C
January 19th 2022Comparing retrospective echocardiogram data from 60 controls and 60 children with MIS-C, a team of investigators from Children's Hospital of Philadelphia provides an overview of the heart function recovery in children with COVID-19-related MIS-C.
Read More